McKesson (MCK) closed at $1,001.01 on Oct 23, 2026, down 1.1% on the day. The stock is up 15.1% over the past month, up 17.8% over three months, up 22.0% year to date and up 25.8% over the past year. It trades 2.8% below its 52-week high of $1,030.27 and 38.3% above its 52-week low of $723.68. The close sits above its 50-day moving average ($910.08) and above its 200-day moving average ($858.72).
NextPick tracks MCK in its Health Insurers & Services basket alongside UNH, CVS, ELV, CI and COR. As of Oct 23, 2026, the basket's money-flow score is 28 (weak inflow), and the basket is up 1.0% over five sessions. Over the past month MCK ranks 2nd of 10 basket members by price change.
MCK is scheduled to report earnings on Nov 4, 2026.
Form 4 filings over the last 90 days show no open-market purchases and 3 open-market sales by insiders.
McKesson is scheduled to report on Nov 4, 2026.
Yes — the Oct 23, 2026 close of $1,001.01 is 16.6% above the 200-day average of $858.72.
MCK closed 2.8% below its 52-week high of $1,030.27.
NextPick groups MCK with UNH, CVS, ELV, CI and COR in its Health Insurers & Services basket.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, hospital reference labs, nursing homes, hospice and home health care agencies, government facilities, and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
